ATMI and Sartorius Stedim Biotech Extend Global Supply and Marketing Alliance

July 6, 2010

ATMI, Inc. (Danbury, CT), and Sartorius Stedim Biotech S.A. (Aubagne, France) have extended their marketing and distribution alliance by adding new technologies.

ATMI, Inc. (Danbury, CT), and Sartorius Stedim Biotech S.A. (Aubagne, France) have extended their marketing and distribution alliance by adding new technologies. The new agreement grants global marketing and distribution rights to ATMI's patented Magnetic Mixer technology to Sartorius. ATMI's Magnetic Mixer is a mobile, mixing system designed for mixing applications in various volumes. It is used in biopharmaceutical processes that require powerful mixing torque, such as buffer and media preparation, and final product formulation applications.

Under the extended agreement, Sartorius retains continued distribution and marketing rights to ATMI LifeSciences' LevMixer mixing system technology that Sartorius has been marketing since April 2008. The LevMixer system is a single-use mixing system that uses patented technology to levitate and drive a single-use impeller inside sterile bags. It mainly is used for liquid-to-liquid applications in downstream purification and sensitive formulation steps, as well as easy-to-dissolve powders, such as salts and buffers.

The expanded agreement also grants Sartorius rights to ATMI's portfolio of bioreactor-related intellectual property, which allows Sartorius to further enable its line of BIOSTAT CultiBag STR single-use bioreactors.

The supply and marketing agreement is a five-year global agreement containing an additional five-year continuity-of-supply clause.